H.R. 877 · 111th Congress
Patients First Act of 2009
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
ForbesSponsor48 cosponsors · 2 D, 46 R
D
Lipinski
DL
R
Lamborn
RB
R
Bartlett
HB
R
Brown
TF
R
Franks
PH
R
Hoekstra
CL
R
Lummis
PO
R
Olson
JP
R
Pitts
JS
R
Schmidt
LW
R
Westmoreland
JB
R
Boozman
MB
R
Bachmann
EC
R
Cantor
DL
R
Lungren
MS
R
Souder
RB
R
Blunt
RA
R
Alexander
CM
R
Miller
JB
R
Boehner
MP
R
Pence
VF
R
Foxx
JM
R
Miller
CS
R
Smith
AC
R
Crenshaw
JB
R
Bonner
PB
R
Broun
JF
R
Fleming
TM
R
McCotter
TM
R
Murphy
TT
R
Tiahrt
GR
R
Radanovich
HR
R
Rogers
RW
R
Wittman
JG
R
Gresham Barrett
JJ
R
Jordan
BG
R
Goodlatte
BC
R
Cassidy
JH
R
Hensarling
JM
R
Moran
DM
R
Manzullo
RL
R
Latta
BE
D
Ellsworth
FS
R
Sensenbrenner
MB
R
Blackburn
GH
R
Harper
SK
R
King
PR
R
Roe1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Patients First Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and…
What it does: CRS summary · Introduced in House · Feb 4, 2009
Patients First Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act.
Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; (2) is prioritized in terms of potential for near-term clinical benefit in human patients; and (3) may take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.
Requires the Secretary to: (1) report on peer reviewed stem cell research proposals that were not funded; and (2) study and submit recommendations to Congress on any structural changes to the C.W. Bill Young Cell Transplantation Program that would help to expand access to new and future stem cell therapeutic products.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Patients First Act of 2009
Latest action (Feb 9, 2009): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Feb 4, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.